ETFPanda

iShares MSCI Europe ex-UK UCITS ETF

IEUX · IE00B14X4N27 · LSE
iSharesTracks iShares MSCI Europe ex-UK UCITS ETF reference index
€38.90
+0.96% today
60 sessions · price data is free, always
ISIN
IE00B14X4N27
Ticker
IEUX
Theme
Broad market
TER
0.40%
Fund size
€1.1B
Replication
Physical
Distribution
Dist
Currency
EUR
Inception
2005

Liquidity & flows

PRO
Avg. daily volume
Avg. bid–ask spread
1M fund flows
Holdings
340
Unlock full data
Advertisement · 300×250300 × 250 · your banner here
Advertisement970 × 250 billboard

Reach European index investors at the moment they compare funds.

This billboard is available on the IEUX fund page. Brokers, issuers and fintechs — your message sits directly above the screener our readers use to pick their next ETF.

Sponsored

Your product, in the feed our readers actually scan.

580 × 120 in-feed · native in-feed slot

Book this space

Fund profile

Sample reference data
Benchmark index
iShares MSCI Europe ex-UK UCITS ETF reference index
Index provider
MSCI
Replication
Physical — full replication, optimised sampling on the long tail
Rebalancing
Monthly
Securities lending
Not used by this share class
Legal structure
Open-ended ICAV / plc sub-fund
Domicile
Ireland
UCITS
Yes — UCITS V compliant
SFDR classification
Article 9 — sustainable investment objective
Income treatment
Distributing — income paid out in cash
Distribution frequency
Semi-annually
Currency hedging
No — unhedged, currency risk is carried by the investor
Withholding tax
15% US treaty rate on US dividends, no Irish withholding on payouts
UK reporting status
Yes
Savings plans
Available at most German and Austrian brokers
Share class launch
April 2005
Fiscal year end
30 September
Depositary / custodian
J.P. Morgan SE — Dublin Branch

Listings & identifiers

Sample cross-listings
WKN
1VQ6NE
SEDOL
1V2I6PI
Valoren
85753899
Bloomberg
IEUX FP
ExchangeTickerTrading currencyListing
LSEIEUXEURPrimary
XetraIEUXEURCross-listing
LSEIEUXUSDCross-listing
LSEIEUXpGBPCross-listing
Borsa ItalianaIEUXEURCross-listing

Top holdings

Top 10 = 44.6% of the fund · sample data
  1. 1ASML7.42%
  2. 2Novo Nordisk6.53%
  3. 3Nestlé5.74%
  4. 4SAP5.06%
  5. 5LVMH4.45%
  6. 6AstraZeneca3.91%
  7. 7Roche3.44%
  8. 8Shell3.03%
  9. 9Siemens2.67%
  10. 10Novartis2.35%

340 positions in total — the remaining 55.4% sits in the long tail.

Risk, return & total cost

Sample figures — not investment advice
SRRI risk score
5 of 7
3Y volatility
11.1%
Max drawdown
−18.1%

Performance history

PRO
1Y total return
3Y annualised
Tracking difference
Sharpe ratio

What you actually pay each year

Ongoing charge (TER)
0.40%
Portfolio transaction costs
0.05%
of which index licence fee
0.03%
Estimated total cost
0.45%

Excludes your broker's commission and the bid–ask spread you pay on the way in and out.

Advertisement300 × 600 half-page

Sticky placement — stays in view while readers scroll.

Book this space
Advertisement · 728×90728 × 90 · your banner here
Advertisement970 × 250 footer billboard

Reach European index investors at the moment they compare funds.

This billboard is available on the foot of every fund page. Brokers, issuers and fintechs — your message sits directly above the screener our readers use to pick their next ETF.

Advertisement